The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of the Effects of Qili Qiangxin Capsules in Patients With Chronic Heart Failure
Open accessAbstract
OBJECTIVES: The purpose of this study was to assess the effects of qili qiangxin capsules in patients with chronic heart failure (CHF). BACKGROUND: Qili qiangxin capsules are a traditional Chinese medicine that has been approved in China for the treatment of CHF, but the evidence supporting its efficacy remains unclear. METHODS: A total of 512 patients with CHF were enrolled and randomly assigned to receive the placebo or qili qiangxin capsules in addition to their standard medications for the treatment of CHF. The primary endpoint was the reduction or percent change in the plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) level during 12 weeks of treatment. RESULTS: At the 12-week follow-up, a significant reduction in the NT-proBNP level from baseline was observed in both groups, but the qili qiangxin capsule group demonstrated a significantly greater reduction than the placebo group (p = 0.002); 47.95% of patients in the qili qiangxin capsule group demonstrated reductions in NT-proBNP levels of at least 30% compared with 31.98% of patients in the placebo group (p < 0.001). Treatment with qili qiangxin capsules also demonstrated superior performance in comparison to the placebo with respect to New York Heart Association functional classification, left ventricular ejection fraction, 6-min walking distance, and quality of life. CONCLUSIONS: On a background of standard treatment, qili qiangxin capsules further reduced the levels of NT-proBNP. Together, our data suggest that qili qiangxin capsules could be used in combination therapy for CHF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Shengmai (a traditional Chinese herbal medicine) for heart failure
Chen, J., Yao, Y., Chen, H., Kwong, J. S., & Chen, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005052.pub4 · Cited by 72
RetractedESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
Ma, Y.-C., Zuo, L., Chen, J.-H., Luo, Q., Yu, X.-Q., Li, Y., Xu, J.-S., Huang, S.-M., Wang, L.-N., Huang, W., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006040368 · Cited by 1,897
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.013 · Cited by 1,374
Bettencourt, P., Azevedo, A., Pimenta, J., Friões, F., Ferreira, S., & Ferreira, A. (2004) · Circulation · doi:10.1161/01.cir.0000144310.04433.be · Cited by 729
Hartmann, F., Packer, M., Coats, A. J. S., Fowler, M. B., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Anker, S. D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000143059.68996.a7 · Cited by 301
Hobbs, F. D. R., Davis, R. C., Roalfe, A. K., Hare, R., Davies, M. K., & Kenkre, J. E. (2002) · BMJ · doi:10.1136/bmj.324.7352.1498 · Cited by 220
Dongfeng, G., Huang, G., & Jiang, H. (2003) · Chinese journal of cardiovascular diseases · Cited by 106
Zou, Y., Li, L., Ye, Y., Wei, J., Zhou, N., Liang, Y., Gong, H., Li, L., Wu, J., Li, Y., et al. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31823f888f · Cited by 67
Chinese Medicine Shenfu Injection for Heart Failure: A Systematic Review and Meta-Analysis
Song, W., Fa-Feng, C., Xu, L., Lin, C.-R., & Liu, J. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/713149 · Cited by 66
Xiao, H., Song, Y., Li, Y., Liao, Y., & Chen, J. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.09.001 · Cited by 47
Liu, W., Chen, J., Xu, T., Tian, W., Li, Y., Zhang, Z., & Wan, L. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.219 · Cited by 41
Song, Y.-H., Li, B.-S., Chen, X., & Cai, H. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.21.1.117 · Cited by 36
Cited by
Traditional Chinese Medicine for Cardiovascular Disease
Hao, P., Jiang, F., Cheng, J., Ma, L., Zhang, Y., & Zhao, Y. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.041 · Cited by 580
Self-citationCheng, C.-W., Wu, T.-X., Shang, H.-C., Li, Y.-P., Altman, D. G., Moher, D., Bian, Z.-X., & for the CONSORT-CHM Formulas 2017 Group* (2017) · Annals of Internal Medicine · doi:10.7326/m16-2977 · Cited by 323
Ren, J., Fu, L., Nile, S. H., Zhang, J., & Kai, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00753 · Cited by 305
Self-citationMetaflammation in glucolipid metabolic disorders: Pathogenesis and treatment
Xiong, P., Zhang, F., Liu, F., Zhao, J., Huang, X., Luo, D., & Guo, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114545 · Cited by 59
Metadata
- Authors
- Li, X., Zhang, J., Huang, J., Ma, A., Yang, J., Li, W., Wu, Z., Yao, C., Zhang, Y., Yao, W., Zhang, B., & Gao, R.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 62
- Issue
- 12
- Pages
- 1065-1072
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2075463771
- Cited by
- 336
- References
- 14
- FWCI
- 10.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.